ADC BIO: Sterling announces strategic investment in ADC Biotechnology
The announcement follows Sterling†s acquisition of a second US development and manufacturing facility in Wisconsin in September
Read full article »
ADC Bio is a UK-based biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer.
Read more